Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (10)

2026

  1. Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomas

    Genes and Diseases, Vol. 13, Núm. 2

2025

  1. DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid Cancer

    Thyroid, Vol. 35, Núm. 5, pp. 494-507

  2. Expression of Homo Sapiens (Hsa)-miR-139-5p as a Clinically Feasible Prognostic Marker for Differentiated Thyroid Cancer

    Laboratory Investigation, Vol. 105, Núm. 10

  3. Multicenter study correlating molecular characteristics and clinical outcomes of cancer cases with patient-derived organoids

    Journal of Experimental and Clinical Cancer Research, Vol. 44, Núm. 1

  4. Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 31, Núm. 9, pp. 1644-1656

2024

  1. Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer

    The Journal of clinical investigation, Vol. 134, Núm. 10

2023

  1. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  2. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

    Frontiers in Immunology, Vol. 14

2022

  1. MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer

    Clinical and Translational Oncology, Vol. 24, Núm. 12, pp. 2432-2440

2013

  1. Acute up-regulation of the rat brain somatostatin receptor-effector system by leptin is related to activation of insulin signaling and may counteract central leptin actions

    Neuroscience, Vol. 252, pp. 289-301